A DWI histogram-based nomogram for preoperative prediction of pathogens and antibiotic resistance in perianal abscesses

基于DWI直方图的列线图用于术前预测肛周脓肿的病原体和抗生素耐药性

阅读:3

Abstract

PURPOSE: To develop nomograms based on diffusion-weighted imaging (DWI) histogram parameters and clinical features to preoperatively predict pathogen type and extended-spectrum β-lactamase (ESBL) infection in perianal abscesses. METHODS: We retrospectively analyzed 157 surgically confirmed patients, stratified by pathogen type (Escherichia coli, n = 110; Klebsiella pneumoniae, n = 47) and ESBL test results (ESBL-negative, n = 91; ESBL-positive, n = 30). Ninety-seven apparent diffusion coefficient (ADC) histogram parameters were extracted. Histogram features selected using least absolute shrinkage and selection operator (LASSO) regression, together with clinical variables identified by univariate logistic regression, were incorporated into multivariate logistic regression models to construct nomograms. Internal validation used 1,000 bootstrap resamples. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), the Hosmer-Lemeshow test, calibration curves, and decision curve analysis (DCA). RESULTS: The pathogen discrimination model, integrating an ADC-derived composite score (ADC_Score) based on 20 retained histogram features with age, diabetes, and hypertension, achieved an AUC of 0.897, sensitivity of 0.872, and specificity of 0.809. The ESBL prediction model, incorporating ADC_Score based on 13 retained features together with white blood cell count (WBC) and age, yielded an AUC of 0.823, sensitivity of 0.867, and specificity of 0.659. Calibration curves and the Hosmer-Lemeshow test indicated good agreement between predicted and observed probabilities, and DCA suggested potential net benefit for both models within the internally validated cohort. CONCLUSION: DWI histogram-based nomograms demonstrated promising performance for pathogen prediction in perianal abscesses, while the incremental value for ESBL prediction was limited. These models represent an internally validated development study and require external validation before clinical application.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。